Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
LSE:FAB
Price:
12.5
GBX
Market Closed
Market Cap:
£15.6m
Cash Flow Statement
Cash Flow Statement
Fusion Antibodies PLC
Fusion Antibodies PLC
Currency: GBP
| Mar-2018 | Sep-2018 | Mar-2019 | Sep-2019 | Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||
| Net Income |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(3)
|
(3)
|
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(1)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
1
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
2
|
2
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(0)
|
0
|
(0)
|
(1)
|
0
|
(0)
|
(1)
|
(0)
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Operating Activities |
0
N/A
|
(0)
N/A
|
(1)
-162%
|
(1)
-10%
|
(0)
+87%
|
(0)
-110%
|
(1)
-238%
|
(1)
+20%
|
(0)
+64%
|
(1)
-77%
|
(2)
-206%
|
(2)
-34%
|
(2)
+25%
|
(1)
+34%
|
(1)
-17%
|
(1)
+14%
|
|
| Investing Cash Flow | |||||||||||||||||
| Capital Expenditures |
(0)
|
(2)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(2)
-246%
|
(1)
+10%
|
(0)
+86%
|
(0)
+47%
|
(0)
-223%
|
(0)
-9%
|
(0)
+23%
|
(0)
+8%
|
(0)
-65%
|
(0)
+74%
|
0
N/A
|
0
-100%
|
0
+200%
|
(0)
N/A
|
(0)
-1 240%
|
|
| Financing Cash Flow | |||||||||||||||||
| Net Issuance of Common Stock |
5
|
5
|
0
|
0
|
0
|
3
|
3
|
0
|
0
|
0
|
0
|
2
|
3
|
1
|
1
|
1
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other |
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
5
N/A
|
5
+0%
|
(0)
N/A
|
(0)
-234%
|
(0)
-99%
|
3
N/A
|
3
+2%
|
(0)
N/A
|
(0)
+14%
|
0
N/A
|
0
-99%
|
1
+46 033%
|
3
+100%
|
1
-60%
|
1
-53%
|
1
+100%
|
|
| Change in Cash | |||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Net Change in Cash |
4
N/A
|
3
-38%
|
(3)
N/A
|
(1)
+41%
|
(0)
+70%
|
2
N/A
|
1
-40%
|
(1)
N/A
|
(1)
+49%
|
(1)
-24%
|
(2)
-135%
|
(1)
+61%
|
1
N/A
|
(0)
N/A
|
(1)
-1 650%
|
(0)
+78%
|
|
| Free Cash Flow | |||||||||||||||||
| Free Cash Flow |
(0)
N/A
|
(2)
-433%
|
(2)
-27%
|
(1)
+44%
|
(0)
+81%
|
(1)
-151%
|
(2)
-122%
|
(1)
+20%
|
(1)
+51%
|
(1)
-71%
|
(2)
-87%
|
(2)
-13%
|
(2)
+16%
|
(1)
+34%
|
(1)
-17%
|
(1)
+9%
|
|
Switch to:
Switch to:
See Also
Discover More
